Wall Street analysts expect Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Rating) to report $210.00 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have made estimates for Axcelis Technologies’ earnings. Axcelis Technologies reported sales of $147.27 million during the same quarter last year, which indicates a positive year over year growth rate of 42.6%. The company is expected to issue its next earnings report on Monday, January 1st.
On average, analysts expect that Axcelis Technologies will report full-year sales of $854.25 million for the current year, with estimates ranging from $853.50 million to $855.00 million. For the next fiscal year, analysts expect that the business will post sales of $905.30 million, with estimates ranging from $885.60 million to $925.00 million. Zacks Investment Research’s sales averages are an average based on a survey of sell-side research analysts that cover Axcelis Technologies.
Axcelis Technologies (NASDAQ:ACLS – Get Rating) last posted its earnings results on Wednesday, May 4th. The semiconductor company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.25. Axcelis Technologies had a net margin of 16.88% and a return on equity of 23.53%. The business had revenue of $203.60 million for the quarter, compared to analysts’ expectations of $193.12 million. During the same period in the prior year, the company posted $0.48 EPS. The business’s revenue for the quarter was up 53.3% compared to the same quarter last year.
NASDAQ ACLS opened at $58.65 on Friday. Axcelis Technologies has a 1 year low of $33.36 and a 1 year high of $83.74. The company has a debt-to-equity ratio of 0.08, a current ratio of 4.40 and a quick ratio of 3.02. The stock has a market capitalization of $1.94 billion, a PE ratio of 16.16 and a beta of 1.67. The company’s 50 day simple moving average is $64.03 and its two-hundred day simple moving average is $64.75.
In related news, CEO Mary G. Puma sold 11,000 shares of the stock in a transaction on Wednesday, March 16th. The shares were sold at an average price of $69.23, for a total transaction of $761,530.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Joseph P. Keithley sold 3,000 shares of the stock in a transaction on Friday, February 25th. The shares were sold at an average price of $69.05, for a total transaction of $207,150.00. The disclosure for this sale can be found here. Insiders sold a total of 22,636 shares of company stock worth $1,580,886 in the last three months. Insiders own 2.15% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the stock. Charles Schwab Investment Management Inc. grew its holdings in shares of Axcelis Technologies by 23.9% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 299,180 shares of the semiconductor company’s stock valued at $22,598,000 after purchasing an additional 57,646 shares during the last quarter. Quantedge Capital Pte Ltd bought a new stake in Axcelis Technologies in the 1st quarter worth $566,000. Penserra Capital Management LLC bought a new stake in Axcelis Technologies in the 1st quarter worth $6,099,000. Prudential Financial Inc. grew its holdings in Axcelis Technologies by 195.8% in the 1st quarter. Prudential Financial Inc. now owns 201,281 shares of the semiconductor company’s stock worth $15,202,000 after acquiring an additional 133,245 shares during the last quarter. Finally, Federated Hermes Inc. grew its holdings in Axcelis Technologies by 1.9% in the 1st quarter. Federated Hermes Inc. now owns 233,601 shares of the semiconductor company’s stock worth $17,644,000 after acquiring an additional 4,443 shares during the last quarter. 83.38% of the stock is currently owned by institutional investors.
Axcelis Technologies Company Profile (Get Rating)
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia. The company offers high energy, high current, and medium current implanters for various application requirements.
- Get a free copy of the StockNews.com research report on Axcelis Technologies (ACLS)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.